Shingrix will now challenge Merck & Co.'s Zostavax, and is looking to displace it as the shingles vaccine of choice in the US and beyond. However it must first gain recommendation from a key US ...

Two doses of Shingrix, however, was around 73% effective after the third year. Previously, Zostavax (the live zoster vaccine) was offered to older and immunocompromised adults to prevent shingles ...

A study published in Nature Medicine suggests that people administered Shingrix have a lower risk of dementia compared to those given Zostavax - an older shingles shot based on a different ...

Zostavax. It was a live vaccine, and acyclovir did have to be stopped before receiving the vaccination. This is not the case with the new recombinant vaccine, Shingrix, which I strongly recommend ...